Search Results

This report provides methodological information on how to obtain estimates of behavioral health outcomes for populations living on and off tribal lands and provides some initial estimates using NSDUH 2005 to 2014 data.

This report presents data from the 2015 National Survey on Drug Use and Health (NSDUH) regarding the perceived harmfulness of using cigarettes,alcohol, and specific illicit drugs and the perceived availability of substances. Estimates are presented for specific age groups. Estimates of the perceived great risk of harm associated with the...

This report presents findings from the 2015 National Survey on Drug Use and Health (NSDUH) on the use and misuse of prescription psychotherapeutic drugs (i.e., pain relievers, tranquilizers, stimulants, and sedatives) in the past year for the population aged 12 or older in the United States. The report presents additional...

Describes emergency department (ED) visits involving the nonmedical use of narcotic pain relievers (opioids) using data from the Drug Abuse Warning Network (DAWN). The drugs most commonly combined with narcotic pain relievers in ED visits; trends for narcotic pain relievers (2005-2011); demographic characteristics of narcotic pain reliever-related visits in 2011...

This report presents data from the 2002 through 2014 National Surveys on Drug Use and Health (NSDUHs) for trends in people’s perceptions of great risk of harm associated with the use of cigarettes, alcohol, and specific illicit drugs and the perceived availability of substances. The data are presented for the...

This short report uses data on drug-related emergency department (ED) visits from the Drug Abuse Warning Network to look at 2011 ED visits involving synthetic cannabinoids. It shows trends compared to 2010 by gender, age group, the age distribution of patients, the drugs most commonly combined with synthetic cannabinoids and...

This report describes changes in the 2014 and 2015 NSDUHs that were designed to increase the efficiency of data collection and processing and to improve the quality of the data collected. In 2014, changes were made in the sample sizes allocated to each state and to different age groups in...

This spotlight uses 2013 National Survey on Drug Use and Health to assess race/ethnic differences in the past year nonmedical use of prescription pain relievers among those aged 12 or older.

This report describes the results of data collection efforts conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Centers for Disease Control and Prevention (CDC) related to the behavioral health (mental health and substance use) of residents of the Gulf Coast affected by the Deepwater Horizon...

This report presents estimates of the numbers and percentages of adults aged 18 or older with past 12-month mental disorders, as assessed by the Mental Health Surveillance Study (MHSS) clinical study, a subset to the 2008 to 2012 National Survey of Drug Use and Health (NSDUH). The assessment included a...

This spotlight uses 2002 to 2012 National Survey on Drug Use and Health (NSDUH) to assess receipt of substance use prevention messages by youth aged 12 to 17 by whether the youth lives with foster parents, biological parents, or adoptive parents.

This short report uses 2010 to 2012 National Survey on Drug Use and Health (NSDUH) to assess any mental illness/serious mental illness and treatment among those ages 18 to 25 and major depressive episodes and treatment among those aged 16 to 17. Results are shown by residential stability, employment, education...

This report uses 2013 National Survey on Drug Use and Health (NSDUH) to assess the prevalence of substance use and mental disorders among those aged 12 or older, adolescents aged 12 to 17, and adults aged 18 or older and the receipt of treatment/services for behavioral health issues. The 2013...

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.

This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,